Quantitated transcript haplotypes (QTH) of AGTR1, reduced abundance of mRNA haplotypes containing 1166C (rs5186:A>C), and relevance to metabolic syndrome traits

Human Mutation

Volumn 28, Issue 4, 2007, Pages 365-373

  Abdollahi, Mohammad R ^a,b   Lewis, Rohan M ^a   Gaunt, Tom R ^a   Cumming, Debbie V E ^a   Rodriguez, Santiago ^a   Rose Zerilli, Matthew ^a   Collins, Andrew R ^a   Syddall, Holly E ^a   Howell, William M ^a   Cooper, Cyrus ^a   Godfrey, Keith M ^a   Cameron, Iain T ^a   Day, Ian N M ^a,c  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c Bristol Laboratory   (United Kingdom)

Author keywords

ACE; AGTR1; Angiotensin converting enzyme; Angiotensin II type 1 receptor; Gene expression; Haplotype; Insertion deletion

Indexed keywords

ADENINE; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; COMPLEMENTARY DNA; CYTOSINE; DIPEPTIDYL CARBOXYPEPTIDASE; MESSENGER RNA;

ADULT; AGED; AGTR1 GENE; ALLELE; ARTICLE; FEEDBACK SYSTEM; FEMALE; GENE; GENE EXPRESSION; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC TRAIT; GENOTYPE; HAPLOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NUCLEOTIDE SEQUENCE; PHENOTYPE; PLACENTA; PRIORITY JOURNAL; PROMOTER REGION; QUANTITATED TRANSCRIPT HAPLOTYPE; QUANTITATIVE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; UNITED KINGDOM;

AGED; ALLELES; FEMALE; HAPLOTYPES; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PLACENTA; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTOR, ANGIOTENSIN, TYPE 1; RNA, MESSENGER;

EID: 34047227863     PISSN: 10597794     EISSN: None     Source Type: Journal    
DOI: 10.1002/humu.20454     Document Type: Article

References (55)

1. Abdollahi MR, Gaunt TR, Syddall HE, Cooper C, Phillips DI, Ye S, Day IN. 2005. Angiotensin II type I receptor gene polymorphism: anthropometric and metabolic syndrome traits. J Med Genet 42:396-401.
2. Barker DJ, Osmond C. 1986. Infant mortality, childhood nutrition, and ischaemic heart disease in England and Wales. Lancet 1:1077-1081.
3. Barratt BJ, Payne F, Lowe CE, Hermann R, Healy BC, Harold D, Concannon P, Gharani N, McCarthy MI, Olavesen MG, McCormack R, Guja C, Ionescu-Tirgoviste C, Undlien DE, Ronningen KS, Gillespie KM, Tuomilehto-Wolf E, Tuomilehto J, Bennett ST, Clayton DG, Cordell HJ, Todd JA. 2004. Remapping the insulin gene/IDDM2 locus in type 1 diabetes. Diabetes 53:1884-1889.
4. Benetos A. 1995. Relation between cardiac hypertrophy and changes in the large arterial trunks. Role of the renin-angiotensin system. Arch Mal Coeur Vaiss 88:21-24. [French]
5. Benetos A, Gautier S, Ricard S, Topouchian J, Asmar R, Poirier O, Larosa E, Guize L, Safar M, Soubrier F, Cambien F. 1996. Influence of angiotensin-converting enzyme and angiotensin II type 1 receptor gene polymorphisms on aortic stiffness in normotensive and hypertensive patients. Circulation 94:698-703.
6. Cambien F, Leger J, Mallet C, Levy-Marchal C, Collin D, Czernichow P. 1998. Angiotensin I-converting enzyme gene polymorphism modulates the consequences of in utero growth retardation on plasma insulin in young adults. Diabetes 47:470-475.
7. Chistiakov DA, Kobalova ZD, Tereshchenko SN, Moiseev SV, Nosikov VV. 2000. Polymorphism of vascular angiotensin II receptor gene and cardiovascular disorders. Ter Arkh 72:27-30. [Russian]
8. Cucca F, Lampis R, Congia M, Angius E, Nutland S, Bain SC, Barnett AH, Todd JA. 2001. A correlation between the relative predisposition of MHC class II alleles to type 1 diabetes and the structure of their proteins. Hum Mol Genet 10:2025-2037.
9. Curnow KM, Pascoe L, White PC. 1992. Genetic analysis of the human type-1 angiotensin II receptor. Mol Endocrinol 6:1113-1118.
10. Curnow KM, Pascoe L, Davies E, White PC, Corvol P, Clauser E. 1995. Alternatively spliced human type I angiotensin II receptor mRNAs are translated at different efficiencies and encode two receptor isoforms. Mol Endocrinol 9:1250-1262.
11. Day IN, Chen XH, Gaunt TR, King TH, Voropanov A, Ye S, Rodriguez S, Syddall HE, Sayer AA, Dennison EM, Tabassum F, Barker DJ, Cooper C, Phillips DI. 2004. Late life metabolic syndrome, early growth, and common polymorphism in the growth hormone and placental lactogen gene cluster. J Clin Endocrinol Metab 89:5569-5576.
12. Fall CH, Osmond C, Barker DJ, Clark PM, Hales CN, Stirling Y, Meade TW. 1995. Fetal and infant growth and cardiovascular risk factors in women. BMJ 310:428-432.
13. Farrall M, Keavney B, McKenzie C, Delepine M, Matsuda F, Lathrop GM. 1999. Fine-mapping of an ancestral recombination breakpoint in DCP1. Nat Genet 23:270-271.
14. Gaunt TR, Hinks LJ, Rassoulian H, Day IN. 2003. Manual 768 or 384 well microplate gel "dry" electrophoresis for PCR checking and SNP genotyping. Nucleic Acids Res 3I:e48.
15. Giacchetti G, Faloia E, Mariniello B, Sardu C, Gatti C, Camilloni MA, Guerrieri M, Mantero F. 2002. Overexpression of the renin-angiotensin system in human visceral adipose tissue in normal and overweight subjects. Am J Hypertens 15:381-388.
16. Guyatt GH, Devereaux PJ. 2004. A review of heart failure treatment. Mt Sinai J Med 71:47-54.
17. Hales CN, Barker DJ, Clark PM, Cox LJ, Fall C, Osmond C, Winter PD. 1991. Fetal and infant growth and impaired glucose tolerance at age 64. BMJ 303:1019-1022.
18. Hugot JP, Chamaillard M, Zouali H, Lesage S, Cezard JP, Belaiche J, Almer S, Tysk C, O'Morain CA, Gassull M, Binder V, Finkel Y, Cortot A, Modigliani R, Laurent-Puig P, Gower-Rousseau C, Macry J, Colombel JF, Sahbatou M, Thomas G. 2001. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411:599-603.
19. Ishihata A, Uno S, Guo DF, Katano Y, Inagami T. 1998. Inhibition of the expression of the gene for the angiotensin AT1 receptor by angiotensin II in the rat adrenal gland. Eur J Pharmacol 350:129-139.
20. Kainulainen K, Perola M, Terwilliger J, Kaprio J, Koskenvuo M, Syvanen AC, Vartiainen E, Peltonen L, Kontula K. 1999. Evidence for involvement of the type 1 angiotensin II receptor locus in essential hypertension. Hypertension 33:844-849.
21. Keavney B, McKenzie CA, Connell JM, Julier C, Ratcliffe PJ, Sobel E, Lathrop M, Farrall M. 1998. Measured haplotype analysis of the angiotensin-I converting enzyme gene. Hum Mol Genet 7:1745-1751.
22. Kennedy GC, German MS, Rutter WJ. 1995. The minisatellite in the diabetes susceptibility locus IDDM2 regulates insulin transcription. Nat Genet 9:293-298.
23. Kislauskis EH, Zhu X, Singer RH. 1994. Sequences responsible for intracellular localization of beta-actin messenger RNA also affect cell phenotype. J Cell Biol 127:441-451.
24. Knight JC. 2004. Allele-specific gene expression uncovered. Trends Genet 20:113-116.
25. Kralovicova J, Gaunt TR, Rodriguez S, Wood PJ, Day IN, Vorechovsky I. 2006. Variants in the human insulin gene that affect pre-mRNA splicing: is -23HphI a functional single nucleotide polymorphism at IDDM2? Diabetes 55:260-264.
26. Lareau LF, Green RE, Bhatnagar RS, Brenner SE. 2004. The evolving roles of alternative splicing. Curr Opin Struct Biol 14:273-282.
27. Laskowska M, Leszczynska-Gorzelak B, Oleszczuk J. 2003. Placental angiotensin II receptor AT1R in normotensive patients and its correlation between infant birth weight. Eur J Obstet Gynecol Reprod Biol 109:166-170.
28. Le Noble FA, Hekking JW, Van Straaten HW, Slaaf DW, Struyker Boudier HA. 1991. Angiotensin II stimulates angiogenesis in the chorio-allantoic membrane of the chick embryo. Eur J Pharmacol 195:305-306.
29. Lucassen AM, Julier C, Beressi JP, Boitard C, Froguel P, Lathrop M, Bell JI. 1993. Susceptibility to insulin dependent diabetes mellitus maps to a 4.1 kb segment of DNA spanning the insulin gene and associated VNTR. Nat Genet 4:305-310.
30. Maniatis N, Collins A, Gibson J, Zhang W, Tapper W, Morton NE. 2004. Positional cloning by linkage disequilibrium. Am J Hum Genet 74:846-855.
31. Martin MM, Willardson BM, Burton GF, White CR, McLaughlin JN, Bray SM, Ogilvie JW Jr, Elton TS. 2001. Human angiotensin II type 1 receptor isoforms encoded by messenger RNA splice variants are functionally distinct. Mol Endocrinol 15:281-293.
32. McKenzie CA, Abecasis GR, Keavney B, Forrester T, Ratcliffe PJ, Julier C, Council JM, Bennett F, McFarlane-Anderson N, Lathrop GM, Cardon LR. 2001. Trans-ethnic fine mapping of a quantitative trait locus for circulating angiotensin I-converting enzyme (ACE). Hum Mol Genet 10:1077-1084.
33. McKenzie CA, Sinsheimer JS, Adeyemo AA, Cox RD, Southam L, Hugill A, Bouzekri N, Lathrop M, Forrester TE, Cooper RS, Ward R. 2005. SNP haplotypes in the angiotensin I-converting enzyme (ACE) gene: analysis of Nigerian family data using gamete competition models. Ann Hum Genet 69:227-232.
34. Meinsma D, Holthuizen PE, Van den Brande JL, Sussenbach JS. 1991. Specific enclonucleolytic cleavage of IGF-II mRNAs. Biochem Biophys Res Commun 179:1509-1516.
35. Miller BC, Eckman EA, Sambamurti K, Dobbs N, Chow KM, Eckman CB, Hersh LB, Thiele DL. 2003. Amyloid-beta peptide levels in brain are inversely correlated with insulysin activity levels in vivo. Proc Natl Acad Sci USA 100:6221-6226.
36. Misquitta CM, Iyer VR, Werstiuk ES, Grover AK. 2001. The role of 3′-untranslated region (3′-UTR) mediated mRNA stability in cardiovascular pathophysiology. Mol Cell Biochem 224:53-67.
37. Montgomery HE, Clarkson P, Dollery CM, Prasad K, Losi MA, Hemingway H, Statters D, Jubb M, Girvain M, Varnava A, World M, Deanfield J, Talmud P, McEwan JR, McKenna WJ, Humphries S. 1997. Association of angiotensin-converting enzyme gene I/D polymorphism with change in left ventricular mass in response to physical training. Circulation 96:741-747.
38. Montgomery HE, Marshall R, Hemingway H, Myerson S, Clarkson P, Dollery C, Hayward M, Holliman DE, Jubb M, World M, Thomas EL, Brynes AE, Saeed N, Barnard M, Bell JD, Prasad K, Rayson M, Talmud PJ, Humphries SE. 1998. Human gene for physical performance. Nature 393:221-222.
39. Nalogowska-Glosnicka K, Lacka BI, Zychma MJ, Grzeszczak W, Zukowska-Szczechowska E, Poreba R, Michalski B, Kniazewski B, Rzempoluch J. 2000. Angiotensin II type 1 receptor gene A1166C polymorphism is associated with the increased risk of pregnancy-induced hypertension. Med Sci Monit 6:523-529.
40. Nickenig G, Murphy TJ. 1996. Enhanced angiotensin receptor type 1 mRNA degradation and induction of polyribosomal mRNA binding proteins by angiotensin II in vascular smooth muscle cells. Mol Pharmacol 50:743-751.
41. Pende A, Giacche M, Castigliola L, Contini L, Passerone G, Patrone M, Port JD, Lotti G. 1999. Characterization of the binding of the RNA-binding protein AUF1 to the human AT(1) receptor mRNA. Biochem Biophys Res Commun 266:609-614.
42. Poirier O, Georges JL, Ricard S, Arveiler D, Ruidavets JB, Luc G, Evans A, Cambien F, Tiret L. 1998. New polymorphisms of the angiotensin II type 1 receptor gene and their associations with myocardial infarction and blood pressure: the ECTIM study. Etude Cas-Temoin de l'Infarctus du Myocarde. J Hypertens 16:1443-1447.
43. Rieder MJ, Taylor SL, Clark AG, Nickerson DA. 1999. Sequence variation in the human angiotensin converting enzyme. Nat Genet 22:59-62.
44. Sayer AA, Cooper C, Evans JR, Rauf A, Wormald RP, Osmond C, Barker DJ. 1998. Are rates of ageing determined in utero? Age Ageing 27:579-583.
45. Schupp M, Janke J, Clasen R, Unger T, Kintscher U. 2004. Angiotensin type 1 receptor blockers induce peroxisome proliferator-activated receptor-gamma activity. Circulation 109:2054-2057.
46. Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, Roses AD. 1993. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA 90:1977-1981.
47. Thekkumkara TJ, Thomas WG, Motel TJ, Baker KM. 1998. Functional role for the angiotensin II receptor (AT1A) 3′-untranslated region in determining cellular responses to agonist: evidence for recognition by RNA binding proteins. Biochem J 329:255-264.
48. Tiret L, Blanc H, Ruidavets JB, Arveiler D, Luc G, Jeunemaitre X, Tichet J, Mallet C, Poirier O, Plouin PF, Cambien F. 1998. Gene polymorphisms of the renin-angiotensin system in relation to hypertension and parental history of myocardial infarction and stroke: the PEGASE study. Projet d'Etude des Genes de l'Hypertension Arterielle Severe a moderee Essentielle. J Hypertens 16:37-44.
49. Tiret L, Rigat B, Visvikis S, Breda C, Corvol P, Cambien F, Soubrier F. 1992. Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet 51:197-205.
50. Tower C, Chappell S, Acharya M, Crane R, Szolin S, Symonds L, Chevins H, Kalsheker N, Baker P, Morgan L. 2006. Altered transmission of maternal angiotensin II receptor haplotypes in fetal growth restriction. Hum Mutat 27:138-144.
51. Ueda H, Howson JM, Esposito L, Heward J, Snook H, Chamberlain G, Rainbow DB, Hunter KM, Smith AN, Di Genova G, Herr MH, Dahlman I, Payne F, Smyth D, Lowe C, Twells RC, Howlett S, Healy B, Nutland S, Rance HE, Everett V, Smink LJ, Lam AC, Cordell HJ, Walker NM, Bordin C, Hulme J, Motzo C, Cucca F, Hess JF, Metzker ML, Rogers J, Gregory S, Allahabadia A, Nithiyananthan R, Tuomilehto-Wolf E, Tuomilehto J, Bingley P, Gillespie KM, Undlien DE, Ronningen KS, Guja C, Ionescu-Tirgoviste C, Savage DA, Maxwell AP, Carson DJ, Patterson CC, Franklyn JA, Clayton DG, Peterson LB, Wicker LS, Todd JA, Gough SC. 2003. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 423:506-511.
52. Warnecke C, Surder D, Curth R, Fleck E, Regitz-Zagrosek V. 1999. Analysis and functional characterization of alternatively spliced angiotensin II type 1 and 2 receptor transcripts in the human heart. J Mol Med 77:718-727.
53. Yamada T, Horiuchi M, Dzau VJ. 1996. Angiotensin II type 2 receptor mediates programmed cell death. Proc Natl Acad Sci USA 93:156-160.
54. Yang X, Pratley RE, Baier LJ, Horikawa Y, Bell GI, Bogardus C, Permana PA. 2001. Reduced skeletal muscle calpain-10 transcript level is due to a cumulative decrease in major isoforms. Mol Genet Metab 73:111-113.
55. Zhu X, Yan D, Cooper RS, Luke A, Ikeda MA, Chang YP, Weder A, Chakravarti A. 2003. Linkage disequilibrium and haplotype diversity in the genes of the renin-angiotensin system: findings from the family blood pressure program. Genome Res 13:173-181.